Federated Hermes
ALXN

Federated Hermes’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-3,915
Closed -$719K 2377
2021
Q2
$719K Sell
3,915
-1,036
-21% -$190K ﹤0.01% 1410
2021
Q1
$757K Sell
4,951
-4,696
-49% -$718K ﹤0.01% 1469
2020
Q4
$1.51M Sell
9,647
-196,153
-95% -$30.6M ﹤0.01% 1168
2020
Q3
$23.6M Buy
205,800
+57,518
+39% +$6.58M 0.06% 376
2020
Q2
$16.6M Sell
148,282
-47,150
-24% -$5.29M 0.04% 427
2020
Q1
$17.5M Buy
195,432
+84,025
+75% +$7.54M 0.05% 362
2019
Q4
$12M Buy
111,407
+22,094
+25% +$2.39M 0.03% 554
2019
Q3
$8.75M Buy
89,313
+85,934
+2,543% +$8.42M 0.02% 608
2019
Q2
$442K Sell
3,379
-13,278
-80% -$1.74M ﹤0.01% 1455
2019
Q1
$2.25M Buy
16,657
+2,560
+18% +$346K 0.01% 1009
2018
Q4
$1.37M Buy
14,097
+4,559
+48% +$444K ﹤0.01% 1173
2018
Q3
$1.33M Sell
9,538
-6,278
-40% -$873K ﹤0.01% 1258
2018
Q2
$1.96M Sell
15,816
-10,755
-40% -$1.33M 0.01% 1021
2018
Q1
$2.96M Sell
26,571
-167,443
-86% -$18.7M 0.01% 802
2017
Q4
$23.2M Sell
194,014
-376,034
-66% -$45M 0.07% 226
2017
Q3
$80M Sell
570,048
-60,816
-10% -$8.53M 0.23% 90
2017
Q2
$76.8M Buy
630,864
+66,880
+12% +$8.14M 0.22% 89
2017
Q1
$68.4M Sell
563,984
-14,196
-2% -$1.72M 0.2% 98
2016
Q4
$70.7M Buy
578,180
+52,709
+10% +$6.45M 0.21% 91
2016
Q3
$64.4M Buy
525,471
+25,002
+5% +$3.06M 0.19% 99
2016
Q2
$58.4M Buy
500,469
+28,721
+6% +$3.35M 0.17% 101
2016
Q1
$65.7M Buy
471,748
+3,260
+0.7% +$454K 0.2% 90
2015
Q4
$89.4M Buy
468,488
+29,627
+7% +$5.65M 0.28% 71
2015
Q3
$68.6M Buy
438,861
+58,175
+15% +$9.1M 0.22% 86
2015
Q2
$68.8M Buy
380,686
+337,070
+773% +$60.9M 0.21% 95
2015
Q1
$7.56M Sell
43,616
-114,268
-72% -$19.8M 0.02% 510
2014
Q4
$29.2M Buy
157,884
+3,172
+2% +$587K 0.09% 212
2014
Q3
$25.7M Sell
154,712
-2,310
-1% -$383K 0.08% 233
2014
Q2
$24.5M Buy
157,022
+20,151
+15% +$3.15M 0.08% 249
2014
Q1
$20.8M Buy
136,871
+79,952
+140% +$12.2M 0.07% 272
2013
Q4
$7.57M Buy
56,919
+2,701
+5% +$359K 0.03% 520
2013
Q3
$6.3M Buy
54,218
+622
+1% +$72.3K 0.02% 510
2013
Q2
$4.94M Buy
+53,596
New +$4.94M 0.02% 584